Scandinavian Real Heart AB (publ) Changes the Date for the Publication of Its Half-Year Report
Scandinavian Real Heart AB (publ) announces that the company’s half-year report for the period January – June 2026 will be published on August 26, 2026, instead of August 28, 2026, as previously communicated in the company’s financial calendar.
The reason for the change is that work on the half-year report was completed earlier than planned.
The company’s financial calendar on its website will be updated in conjunction with the publication of this press release.
For more information, please contact:
Ina Laura Perkins, CEO
Phone: +46 (0) 70 406 49 21
E-mail: inalaura.perkins@realheart.se
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se
About Us
Scandinavian Real Heart AB (publ) is developing the first artificial heart that mimics the shape, function, and blood flow pattern of the human heart. These unique product features provide completely new opportunities to save lives and give patients a good quality of life while waiting for a heart transplant. In the future, artificial hearts may also become an alternative to transplantation for broader groups of patients with severe heart failure. Realheart® TAH (Total Artificial Heart) is now being evaluated in extensive preclinical trials ahead of a first clinical study in patients. The company's shares are traded on Nasdaq Stockholm First North Growth Market. For more information, visit www.realheart.se